SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
EBITDA as a percentage of revenue
3Y CAGR
+2.7%/yr
vs +5.7%/yr prior
5Y CAGR
+6.4%/yr
Recent deceleration
Acceleration
-2.9pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
5 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 28.47% | +7.2% |
| 2024 | 26.55% | +0.0% |
| 2023 | 26.55% | +1.1% |
| 2022 | 26.27% | +5.4% |
| 2021 | 24.91% | +19.3% |
| 2020 | 20.88% | -6.1% |
| 2019 | 22.23% | +5.4% |
| 2018 | 21.08% | -32.8% |
| 2017 | 31.34% | +3.1% |
| 2016 | 30.41% | - |